Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase NA 3 Phase 4 3 Phase 1 2 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Multiple Myeloma 43 Recurrence 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Neoplasms, Plasma Cell 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Lung Neoplasms 3 Leukemia 3 Immunoglobulin Light-chain Amyloidosis 3 Amyloidosis 3 Myelodysplastic Syndromes 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Smoldering Multiple Myeloma 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Proteostasis Deficiencies 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphodepleting Chemotherapy 1

Interventions

pembrolizumab 44 Nivolumab 29 Gemcitabine 28 Paclitaxel 19 Cisplatin 18 Ipilimumab 15 Carboplatin 14 Cyclophosphamide 13 Capecitabine 12 Dexamethasone 10 Bevacizumab 10 cemiplimab 9 Irinotecan 9 Docetaxel 9 Albumin-Bound Paclitaxel 9 130-nm albumin-bound paclitaxel 9 spartalizumab 8 Pemetrexed 8 Sorafenib 7 Rituximab 7 Cetuximab 7 fludarabine 6 Temozolomide 6 Taxes 6 Radiotherapy 6 Leucovorin 6 Fluorouracil 6 Azacitidine 6 Ascorbic Acid 6 lenvatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasms × Calcium Dobesilate × Clear all

NCT02813135 2026-01-16

ESMART

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡